We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Radcal IBA  Group

Download Mobile App




New Company to Promote Use of Cardiac PET

By HospiMedica staff writers
Posted on 16 Jun 2006
The Bracco Group (Milan, Italy), a developer of diagnostic imaging systems, and Integrated Medical Solutions, LLC (Sterling, VA, USA), a provider of positron emission tomography (PET) imaging centers in the United States, have formed a new company, Integrated Cardiac Solutions, LLC (ICS; Alexandria, VA, USA). More...
ICS will provide turnkey services that enable outpatient cardiology groups and heart centers to implement cardiac PET perfusion imaging technology for the detection of cardiovascular disease.

"The formation of ICS will lead an evolution in the field of cardiology,” said Carlo Medici, president and CEO of Bracco Diagnostics, Inc. (Princeton, NJ, USA). "Practices will now have an unprecedented opportunity to, first and foremost, offer expanded imaging services to their patients and, secondly, to improve the efficiency of their business. ICS and its wide array of services will be there to help them implement cardiac PET perfusion imaging every step of the way.”

Two recent clinical studies indicate that PET perfusion imaging is more accurate in the detection of coronary artery disease than the widely used single photon emission tomography (SPECT) perfusion imaging modality, particularly in women. Furthermore, the average time required for a cardiac PET perfusion test is about 30 minutes, versus three to four hours for the average cardiac SPECT perfusion scan, making cardiac PET more convenient for patients.

Cardiac PET perfusion imaging predominately uses the radionuclide rubidium-82, which can be derived from CardioGen-82 (rubidium Rb 82 generator), the only U.S Food and Drug Administration- (FDA)-approved generator-based cardiac PET perfusion agent. Over the past 18 months, the number of new CardioGen-82 sites has increased by nearly 90%. The adoption of cardiac PET in the outpatient setting is gaining favor among many cardiologists.

"I see ICS filling a missing piece in the rapidly emerging field of cardiac PET perfusion imaging. This venture will create a practical bridge, assisting practices in successfully implementing cardiac PET imaging as a significant and valued element in their patient management options,” stated Bill Abbott, vice president and general manager of nuclear medicine at Bracco Diagnostics.


Related Links:
Bracco Diagnostics
Integrated Cardiac Solutions

Platinum Member
Real-Time Diagnostics Onscreen Viewer
GEMweb Live
Gold Member
Temperature Monitor
ThermoScan Temperature Monitoring Unit
Medical Monitor
VITALMAX 4100SL
Pulmonary Ventilator
OXYMAG
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Surgical Techniques

view channel
Image: Professor Bumsoo Han and postdoctoral researcher Sae Rome Choi of Illinois co-authored a study on using DNA origami to enhance imaging of dense pancreatic tissue (Photo courtesy of Fred Zwicky/University of Illinois Urbana-Champaign)

DNA Origami Improves Imaging of Dense Pancreatic Tissue for Cancer Detection and Treatment

One of the challenges of fighting pancreatic cancer is finding ways to penetrate the organ’s dense tissue to define the margins between malignant and normal tissue. Now, a new study uses DNA origami structures... Read more

Patient Care

view channel
Image: The portable biosensor platform uses printed electrochemical sensors for the rapid, selective detection of Staphylococcus aureus (Photo courtesy of AIMPLAS)

Portable Biosensor Platform to Reduce Hospital-Acquired Infections

Approximately 4 million patients in the European Union acquire healthcare-associated infections (HAIs) or nosocomial infections each year, with around 37,000 deaths directly resulting from these infections,... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.